Neurology News

BOSTON — An evaluation of the Utah Population Health Database showed familial clustering of stiff-person syndrome along with other autoimmune diseases, Justin Abbatemarco, MD, said at the American Academy of Neurology annual meeting.

BOSTON — Mental health symptoms in surrogate decision-makers were highest when patients survived in a dependent state after severe acute brain injury, according to a poster at the American Academy of Neurology annual meeting.

As allergies emerge each spring, so do migraines. The American Migraine Foundation says that 37% of people with allergies also have migraines, compared with 5% of people who do not have allergies, in an association that increases with age.

BOSTON — Treatment with tolebrutinib 60 mg per day was safe and associated with low annualized relapse rate and stable disability through 120 weeks, according to research presented at the American Academy of Neurology annual meeting.

BOSTON — The SemontPlus maneuver led to quicker recovery than the Epley maneuver in patients with posterior canal benign paroxysmal positional vertigo, according to research presented at the American Academy of Neurology annual meeting.

BOSTON — Older adults with atrial fibrillation who underwent catheter ablation developed less cognitive impairment than those receiving only medical management, according to a presenter at the American Academy of Neurology annual meeting.

BOSTON — Now that there are disease-modifying treatments for Alzheimer’s disease, the necessity of identifying “contemporary population-level diagnosis rates of mild cognitive impairment and dementia” is crucial, according to a presenter.

BOSTON — Results from the long-term RESTORE study show patients with Leber hereditary optic neuropathy with ND4 mutation who were treated with Lumevoq had sustained improvement of best-corrected visual acuity in both eyes.

The FDA has granted Noctrix Health its de novo request for the NTX100 Tonic Motor Activation System, the first therapy for patients with moderate to severe, drug-refractory restless legs syndrome, according to a company press release.

BOSTON — Laser interstitial thermal therapy may offer seizure freedom to select patients, particularly those with drug-resistant temporal lobe epilepsy, according to a poster at the American Academy of Neurology annual meeting.